Insider Trading & Ownership - PELLETIER SAUNDRA L

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for PELLETIER SAUNDRA L
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-12-31
Sale
2023-04-26
8:50 pm
Evofem Biosciences Inc. EVFM PELLETIER SAUNDRA L
Chief Executive Officer
50,000 $0 $0 186,722
(Direct)
View
2022-05-27
Purchase
2022-05-31
08:55 am
Evofem Biosciences Inc. EVFM PELLETIER SAUNDRA L
Chief Executive Officer
141,000 $0.3525 $49,703 236,722
(Direct)
View
2021-12-31
Sale
2022-01-04
4:03 pm
Evofem Biosciences Inc. EVFM PELLETIER SAUNDRA L
Chief Executive Officer
300,000 $0 $0 685,837
(Direct)
View
2021-12-20
Purchase
2021-12-20
4:19 pm
Evofem Biosciences Inc. EVFM PELLETIER SAUNDRA L
Chief Executive Officer
135,000 $0.375 $50,625 985,837
(Direct)
View
2021-07-26
Purchase
2021-07-27
06:00 am
Tracon Pharmaceuticals Inc. TCON PELLETIER SAUNDRA L
Director
6,545 $3.82 $25,002 12,045
(Direct)
View
2021-06-10
Purchase
2021-06-10
7:30 pm
Evofem Biosciences Inc. EVFM PELLETIER SAUNDRA L
Chief Executive Officer
50,000 $1.03 $51,500 850,837
(Direct)
View
2021-03-09
Purchase
2021-03-09
6:59 pm
Evofem Biosciences Inc. EVFM PELLETIER SAUNDRA L
Chief Executive Officer
45,249 $2.28 $103,168 906,137
(Direct)
View
2020-09-08
Sale
2020-09-10
8:04 pm
Evofem Biosciences Inc. EVFM PELLETIER SAUNDRA L
Chief Executive Officer
122,500 $3.26 $399,350 360,888
(Direct)
View
2020-06-11
Purchase
2020-06-16
5:24 pm
Tracon Pharmaceuticals Inc. TCON PELLETIER SAUNDRA L
Director
5,500 $2.038 $11,209 10,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-04-19
Option Award
2023-04-21
8:48 pm
N/A
2033-04-18
Tracon Pharmaceuticals Inc. TCON PELLETIER SAUNDRA L
Director
18,000 $0 18,000
(Direct)
View
2022-06-14
Option Award
2022-06-16
9:14 pm
N/A
2032-06-13
Tracon Pharmaceuticals Inc. TCON PELLETIER SAUNDRA L
Director
15,750 $0 15,750
(Direct)
View
2022-02-18
Option Award
2022-02-23
4:04 pm
N/A
2032-02-18
Evofem Biosciences Inc. EVFM PELLETIER SAUNDRA L
Chief Executive Officer
750,000 $0 2,185,837
(Direct)
View
2021-06-10
Option Award
2021-06-24
7:01 pm
N/A
2031-06-09
Tracon Pharmaceuticals Inc. TCON PELLETIER SAUNDRA L
Director
10,500 $0 10,500
(Direct)
View
2021-05-20
Tax Withholding
2021-05-21
4:25 pm
N/A
N/A
Evofem Biosciences Inc. EVFM PELLETIER SAUNDRA L
Chief Executive Officer
105,300 $0.86 800,837
(Direct)
View
2021-02-03
Option Award
2021-02-03
8:05 pm
N/A
2031-02-03
Evofem Biosciences Inc. EVFM PELLETIER SAUNDRA L
Chief Executive Officer
1,200,000 $0 1,560,888
(Direct)
View
2020-06-10
Option Award
2020-06-16
5:24 pm
N/A
2030-06-09
Tracon Pharmaceuticals Inc. TCON PELLETIER SAUNDRA L
Director
4,500 $0 10,000
(Direct)
View
2020-06-05
Tax Withholding
2020-06-08
5:42 pm
N/A
N/A
Evofem Biosciences Inc. EVFM PELLETIER SAUNDRA L
Chief Executive Officer
85,620 $3.31 479,085
(Direct)
View
2020-05-22
Tax Withholding
2020-05-26
5:17 pm
N/A
N/A
Evofem Biosciences Inc. EVFM PELLETIER SAUNDRA L
Chief Executive Officer
84,525 $4.99 564,705
(Direct)
View
2020-05-06
Tax Withholding
2020-05-08
12:31 pm
N/A
N/A
Evofem Biosciences Inc. EVFM PELLETIER SAUNDRA L
Chief Executive Officer
16,905 $5.24 649,230
(Direct)
View